Quick Take Asia

Global Market Quick Take: Asia – May 30, 2025

Macro 6 minutes to read
Saxo Be Invested
APAC Research

Key points:

  • Macro: US appeals court reinstates Trump’s tariffs
  • Equities: S&P 500 lost earlier gains of over 1% after Trump’s tariffs restated, up just 0.4%
  • FX: Dollar weakened amid poor US economic data and new trade uncertainties
  • Commodities: Oil is set for a second weekly decline ahead of the OPEC+ meeting
  • Fixed income: Treasuries lift higher as yields on 20 year and 30 year falls below 5%

------------------------------------------------------------------  0530

Disclaimer: Past performance does not indicate future performance.

Macro: 

  • The US Appeals Court reinstated Trump's tariffs during an appeal, as the Federal Circuit Court reviews filings. The US may ask the Supreme Court to keep tariffs, while the White House called the trade court ruling judicial overreach.
  • The US economy contracted at an annualized rate of 0.2% in Q1 2025, improving from the initial 0.3% decline estimate, marking the first quarterly GDP contraction in three years. The revision was due to stronger fixed investment, offsetting weaker consumer spending and a larger trade drag.
  • Fed Chair Powell met President Trump to discuss economic developments, stressing policy depends on economic data and will support employment and stable prices. Trump said not lowering interest rates is a mistake.
  • Retail sales in Japan grew by 3.3% year-on-year in April 2025, exceeding the previous month's 3.1% gain and market expectations. This marks the 37th consecutive month of growth, supported by rising wages, and the fastest pace since January.
  • Pending home sales in the US fell 6.3% in April 2025, sharply contrasting with the expected 0.9% drop and marking the steepest decline in a year, erasing the revised 5.5% increase in March.
  • Tokyo's core CPI rose 3.6% year-on-year in May 2025, surpassing April's 3.4% and expectations. This highest inflation rate in over two years suggests potential further monetary tightening by the BoJ Governor Ueda reaffirmed the commitment to policy adjustments for inflation targets.

Equities:

  • US - US stocks increased slightly on Thursday amid a mix of earnings optimism and tariff uncertainty. The S&P 500 and Nasdaq each gained 0.4%, while the Dow rose 117 points, buoyed by Nvidia's strong results and positive corporate news like Boeing's production plans. Nvidia shares climbed 3.2%, surpassing quarterly sales estimates thanks to AI chip demand, though US export restrictions on China could reduce next-quarter sales by $8 billion. Market gains were tempered by ongoing legal issues over President Trump's tariffs; a federal court had blocked most tariffs, but a US appeals court reinstated them, causing trade policy uncertainty. Best Buy fell 7% after lowering its full-year forecast due to tariff-related economic concerns. Meanwhile, US GDP contracted by 0.2% in the first quarter, a slight improvement on initial estimates of –0.3%.
  • EU - European stocks reversed early gains on Thursday, with the STOXX 50 closing flat at 5,377 and the STOXX 600 dipping slightly to 548, despite each having increased by over 1% during the day. Initial optimism from a US Court ruling against President Trump's tariffs diminished as investors considered the administration's potential alternative legal measures. Focus shifted to the US economic outlook following weak data release. Auto Trader shares dropped 11.3% due to disappointing annual revenue, while Thyssenkrupp fell 5.4%, and Novo Nordisk and Siemens each declined 2.4%.
  • HK - HSI rose 1.4%, to close at 23,573 on Thursday after a US court ruled against President Trump's broad tariffs. While the White House plans to appeal, the decision raised hopes for lower tariffs. Tech stocks led gains, up 2.5% following Nvidia's strong earnings. Consumer and financial stocks also advanced as UBS raised Hong Kong's 2025 GDP growth forecast to 2.2%. Notable movers included Loapu Gold (+7.6%), Meituan (+6.9%), Kuaishou Tech (+4.7%), and Trip.com (+3.3%). Pharma stocks jumped as China plans drug pricing reforms, with Wuxi Biologics up 9.8% and Innovent Biologics rising 3.1%.

Earnings this week:

  • Friday: No notable earnings.

FX:

  • USD weakened due to soft data releases, including GDP contraction, softer Core PCE, weaker pending sales, and higher jobless claims. Trade uncertainty increased after the Court of International Trade blocked Trump's tariffs, though an appeal temporarily reinstated them. DXY near 100 level.
  • EUR gained strength, reclaiming the 1.1370 level after surpassing its 21-day moving average, driven by dollar selling.
  • GBP was supported but faced resistance around 1.3500, with BoE Governor Bailey's comments having little effect, noting challenges due to inflexible and uncertain supply conditions.
  • JPY strengthened, causing USDJPY to fall below 144 level, influenced by softer US yields following data releases and as stocks lost most of their early gains.
  • Economic data – AU Retail Sales, AU Building Permits, JP Housing Starts, GE Inflation Rate, CA GDP Growth Rate, US Core PCE Pricing Index, US Personal Income, US Personal Spending

Commodities:

  • Oil was heading for a second weekly decline before an OPEC+ meeting likely to increase supply. WTI stayed below $61, and Brent closed near $64. Saudi-led talks will determine July production levels.
  • Gold rebounded near $3,314 an ounce as uncertainties over Trump's tariffs and economic strength persisted. It rose nearly 1% after a federal appeals court temporarily paused the ruling to block tariffs, with broad based dollar weakness.

Fixed income:

  • Treasury futures rebounded reversing earlier losses from Asian hours, with yields falling after GDP data and unexpectedly high jobless claims. This trend continued into the 7-year note auction, which saw strong interest and results surpassing the when-issued level by over two basis points. There was notable demand for Eris SOFR swap futures, with numerous block trades in 5-year and 10-year maturities throughout the afternoon. Australian and New Zealand bonds mirrored Thursday's US Treasuries rally, while Japanese bond futures rose despite higher-than-expected Tokyo inflation and an upcoming two-year note auction.

For a global look at markets – go to Inspiration.

 

Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

Disclaimer

The Saxo Group entities each provide execution-only service, and access to analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Inspiration Disclaimer and (v) Notices applying to Trade Inspiration, Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular, no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Markets or its affiliates.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Select region

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.